Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
It has shown significant promise as an effective intervention against type 2 diabetes (T2D) and excessive body weight, resulting in the United States Food and Drug Administration (FDA) approving its use against both conditions in May 2022 for T2D and November 2023 for obesity
Authentic Product Source All NEXAPH products are distributed exclusively through nexaphstore , ensuring verified authenticity
Wessells H, Fuciarelli K, Hansen J, et al
Guidance from the Centers for Disease Control (CDC) published in 2024 also supports the correlation between weight loss and lowering risk for T2D
US$ 28.00
US$ 23.63
US$ 23.70
